Develop An Intragastric Floating Drug Delivery System of Clarithromycin to Sustain the Release of Clarithromycin

Authors

  • Poonam Kumari
  • Rahul Shukla

Keywords:

GIT, Clarithromycin, Floating Drug delivery System

Abstract

This study aimed to develop an intragastric floating drug delivery system (FDDS) for clarithromycin to prolong its release and improve its bioavailability. Clarithromycin, a macrolide antibiotic, has a short half-life and is poorly absorbed in the gastrointestinal tract, necessitating the development of a controlled-release formulation. Floating beads were formulated using a combination of hydrophilic and hydrophobic polymers to achieve prolonged gastric retention. Various preformulation studies, including drug-excipient compatibility and solubility enhancement, were conducted. The beads were evaluated for buoyancy, drug release profiles, and in vitro dissolution rates. The results indicated that the optimised formulation provided sustained release for 12 h with excellent floating properties. This study underscores the potential of FDDS to enhance the therapeutic efficacy of clarithromycin by extending its gastric residence time and improving patient compliance.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Downloads

Published

2025-05-07

How to Cite

1.
Kumari P, Shukla R. Develop An Intragastric Floating Drug Delivery System of Clarithromycin to Sustain the Release of Clarithromycin. J Neonatal Surg [Internet]. 2025May7 [cited 2025Sep.21];14(21S):227-38. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/5264

Issue

Vol. 14 No. 21S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.